Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
39.59
+0.18 (0.44%)
At close: Dec 4, 2025, 4:00 PM EST
39.62
0.00 (0.00%)
Pre-market: Dec 5, 2025, 6:03 AM EST

Castle Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
343.53332.07219.79137.0494.0962.65
Upgrade
Revenue Growth (YoY)
10.15%51.09%60.38%45.65%50.18%20.79%
Upgrade
Cost of Revenue
68.960.2144.9832.0115.829.69
Upgrade
Gross Profit
274.63271.86174.81105.0378.2652.96
Upgrade
Selling, General & Admin
222.56200.05180.1514386.7448.13
Upgrade
Research & Development
50.1152.0453.6244.929.6513.26
Upgrade
Amortization of Goodwill & Intangibles
16.811.119.018.271.96-
Upgrade
Operating Expenses
289.47263.19242.78196.17118.3461.39
Upgrade
Operating Income
-14.838.67-67.98-91.14-40.08-8.42
Upgrade
Interest Expense
-0.15-0.58-0.01-0.02-0-2.63
Upgrade
Interest & Investment Income
12.2512.9210.623.970.070.37
Upgrade
Other Non Operating Income (Expenses)
0.05-----
Upgrade
EBT Excluding Unusual Items
-2.6921.01-57.37-87.19-40.01-10.69
Upgrade
Gain (Loss) on Sale of Investments
3.880.56----
Upgrade
Other Unusual Items
---18.29-0.49
Upgrade
Pretax Income
-18.9221.56-57.37-68.9-40.01-10.2
Upgrade
Income Tax Expense
-6.683.320.1-1.77-8.720.08
Upgrade
Net Income
-12.2418.25-57.47-67.14-31.29-10.28
Upgrade
Net Income to Common
-12.2418.25-57.47-67.14-31.29-10.28
Upgrade
Shares Outstanding (Basic)
292827262519
Upgrade
Shares Outstanding (Diluted)
292927262519
Upgrade
Shares Change (YoY)
1.04%9.15%2.87%3.65%32.80%118.63%
Upgrade
EPS (Basic)
-0.430.66-2.14-2.58-1.24-0.54
Upgrade
EPS (Diluted)
-0.430.62-2.14-2.58-1.24-0.54
Upgrade
Free Cash Flow
25.3836.54-19.25-47.29-22.475.11
Upgrade
Free Cash Flow Per Share
0.891.25-0.72-1.81-0.890.27
Upgrade
Gross Margin
79.94%81.87%79.53%76.64%83.18%84.54%
Upgrade
Operating Margin
-4.32%2.61%-30.93%-66.51%-42.60%-13.45%
Upgrade
Profit Margin
-3.56%5.49%-26.15%-48.99%-33.26%-16.41%
Upgrade
Free Cash Flow Margin
7.39%11.00%-8.76%-34.51%-23.88%8.16%
Upgrade
EBITDA
7.8324.67-55.65-80.6-36.67-7.95
Upgrade
EBITDA Margin
2.28%7.43%-25.32%-58.81%-38.98%-12.69%
Upgrade
D&A For EBITDA
22.661612.3310.543.410.47
Upgrade
EBIT
-14.838.67-67.98-91.14-40.08-8.42
Upgrade
EBIT Margin
-4.32%2.61%-30.93%-66.51%-42.60%-13.45%
Upgrade
Effective Tax Rate
-15.39%----
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q